Premium Company Profile: OSI Pharmaceuticals

Publication Date	November 2007
Publisher	Datamonitor
Product Type	Report
Pages	60
ISBN Number	not applicable
Product Code	DAT08681

Price

£265.00
approximately: $386 | €306

PDF

PRINT £315 ($459 | €364)

Order above formats by FAX

Summary

OSI Pharmaceuticals' (OSI Pharma) main focus is to discover and develop novel drugs and build innovative commercialized molecular targeted therapies. The company has three marketed products, namely, Tarceva, Novantrone and Macugen for various indications in the areas of oncology, ophthalmology and diabetes.

Scope

Contains corporate strategy, value chain presence and SWOT Analysis
Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors
Includes information on suppliers/ partners, shareholding structure and key employees with biographies

Highlights

OSI Pharma is a research-driven biotechnology company, engaged in the discovery and development of novel drugs and building innovative commercialized molecular targeted therapies.The company markets three products: Tarceva, Novantrone and Macugen. Tarceva.

OSI Pharma's major revenue contributor, is a small molecule designed to target the human epidermal growth factor receptor (HER1) pathway, also known as EGFR, which is critical to cell growth in many cancers, indicated for the treatment of advanced non-small cell lung cancer and pancreatic cancer.

OSI Pharma derives its revenues from marketing of pharmaceutical products and from royalties, license and collaborative agreements consisting payments related to the commercialization of its products in other countries with other pharmaceutical companies.

Reasons to Purchase

Access all the important information and analysis on the company in a single report
Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain
Gain access to company's adjusted five year financial data along with key ratios and market capitalization

Content

Table Of Contents
- Overview
- Catalyst
- Summary
- Company Structure
- Company Overview And Key Facts
- Business Description
- History
- Locations And Subsidiaries
- Company Financials
- Stock Market Performance
- P&L
- Balance Sheet
- Cash Flow
- Business Segment Performance
- Products & Services
- Marketed Products
- Pipeline Products
- Historical Product Sales
- Ac Forecast Product Sales
- Competitors And Strategic Business Relationships
- Key Competitors
- Key Suppliers
- Key Clients
- Shareholding Structure
- Strategy
- Company View
- Corporate Strategy
- Swot Analysis
- Overview
- Strengths
- Weaknesses
- Opportunities
- Threats
- Value Chain Analysis
- Overview
- Discovery And Product Development
- Sales
- Scorecard
- Overview
- Scorecard Analysis
- Key Employees
List Of Key Employees
- Key Employee Biographies
- Financial And Operational Overview
- Financial And Operational Overview
Appendix
- Ask The Analyst
- Datamonitor Consulting
- Disclaimer
Table Of Figures
- Figure 1: Osi Pharmaceuticals - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
- Figure 2: Osi Pharmaceuticals - Key Strategic Revenues, 2002-2006 ($ Mn)
- Figure 3: Osi Pharmaceuticals - Key Strategic Revenues, 2006-2010 ($ Mn)
Table Of Tables
- Table 1: Osi Pharmaceuticals - Key Facts
- Table 2: Osi Pharmaceuticals - Locations And Subsidiaries
- Table 3: Osi Pharmaceuticals - Year-End Share Price And Market Capitalization, 2002-2006 ($)
- Table 4: Osi Pharmaceuticals - Key Events Impacting Share Price Performance
- Table 5: Osi Pharmaceuticals - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
- Table 6: Osi Pharmaceuticals - Operating Cost Ratio Analysis, 2002-2006 (% Of Total Revenues)
- Table 7: Osi Pharmaceuticals - Balance Sheet, 2002-2006 ($ Mn)
- Table 8: Osi Pharmaceuticals - Cash Flow, 2002-2006 ($ Mn)
- Table 9: Osi Pharmaceuticals - Revenue Breakdown, 2002-2006 ($ Mn)
- Table 10: Osi Pharmaceuticals - Marketed Products
- Table 11: Osi Pharmaceuticals - In-House Pipeline Products
- Table 12: Osi Pharmaceuticals - Historical Product Sales, 2002-2006 ($ Mn)
- Table 13: Osi Pharmaceuticals - Forecast Sales, 2006-2010 ($ Mn)
- Table 14: Osi Pharmaceuticals - Key Competitors
- Table 15: Osi Pharmaceuticals - Key Suppliers
- Table 16: Osi Pharmaceuticals - Key Shareholders
- Table 17: Osi Pharmaceuticals - Swot Analysis Summary
- Table 18: Osi Pharmaceuticals - Value Chain Analysis
- Table 19: Osi Pharmaceuticals - Scorecard
- Table 20: Osi Pharmaceuticals - Key Employees
- Table 21: Osi Pharmaceuticals - Financial And Operational Overview